Back
 IJCM  Vol.10 No.4 , April 2019
Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes
Abstract: Although there is ample evidence that non-alcoholic fatty liver disease (NAFLD) is associated with impaired glucose homeostasis in the body, the clinical significance of NAFLD in pregnant women has not been established. Current studies have shown that women with NAFLD during early pregnancy have a significantly increased incidence of gestational diabetes mellitus (GDM) during pregnancy; whereas women with a history of GDM have a significantly increased probability of developing NAFLD in the future. Both may be a manifestation of an etiology in both systems, reflecting the impaired glucose homeostasis and the continuity of insulin resistance. For women with NAFLD found in early pregnancy, it is recommended to closely monitor blood glucose during pregnancy, and if necessary, early intervention to strengthen prenatal and postnatal care. The presence of GDM at a young age in women may be an early marker that helps to screen out women at higher risk of developing a disease before significant metabolic disease, and is of great significance in reducing associated morbidity and mortality.
Cite this paper: Luo, Z. and Wu, Q. (2019) Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes. International Journal of Clinical Medicine, 10, 251-258. doi: 10.4236/ijcm.2019.104019.
References

[1]   Rinella, M.E. (2015) Nonalcoholic Fatty Liver Disease: A Systematic Review. JAMA, 313, 2263-2273.
https://doi.org/10.1001/jama.2015.5370

[2]   Blond, E., Disse, E., Cuerq, C., et al. (2017) EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease in Severely Obese People: Do They Lead to Over-Referral? Diabetologia, 60, 1218-1222.

[3]   Bellentani, S., Scaglioni, F., Marino, M., et al. (2010) Epidemiology of Non-Alcoholic Fatty Liver Disease. Digestive Diseases, 28, 155-161.
https://doi.org/10.1159/000282080

[4]   Wong, V.W., Chan, W.K., Chitturi, S., et al. (2018) Asia-Pacific Working Party on Non-Alcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, Risk Factors and Assessment. Journal of Gastroenterology and Hepatology, 33, 70-85.
https://doi.org/10.1111/jgh.13857

[5]   Zhan, Y., Li, B. and Zhang, C. (2017) Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Modern Medical and Health, 33, 645-646.

[6]   Schwimmer, J.B., Pardee, P.E., Lavine, J.E., et al. (2008) Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease. Circulation, 118, 277-283.
https://doi.org/10.1161/CIRCULATIONAHA.107.739920

[7]   Mellinger, J.L., Pencina, K.M., Massaro, J.M., et al. (2015) Hepatic Steatosis and Cardiovascular Disease Outcomes: An Analysis of the Framingham Heart Study. Journal of Hepatology, 63, 470-476.
https://doi.org/10.1016/j.jhep.2015.02.045

[8]   American Diabetes Association (2018) Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes 2018. Diabetes Care, 41, S13-S27.
https://doi.org/10.2337/dc18-S002

[9]   Eggleston, E.M., LeCates, R.F., Zhang, F., et al. (2016) Variation in Postpartum Glycemic Screening in Women with a History of Gestational Diabetes Mellitus. Obstetrics & Gynecology, 128, 159-167.
https://doi.org/10.1097/AOG.0000000000001467

[10]   Casagrande, S.S., Linder, B. and Cowie, C.C. (2018) Prevalence of Gestational Diabetes and Subsequent Type 2 Diabetes among U.S. Women. Diabetes Research and Clinical Practice, 141, 200-208.
https://doi.org/10.1016/j.diabres.2018.05.010

[11]   De Souza, L.R., Berger, H., Retnakaran, R., et al. (2016) Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. American Journal of Gastroenterology, 111, 665-670.
https://doi.org/10.1038/ajg.2016.43

[12]   Page, L.M. and Girling, J.C. (2011) A Novel Cause for Abnormal Liver Function Tests in Pregnancy and the Puerperium: Non-Alcoholic Fatty Liver Disease. BJOG, 118, 1532-1535.
https://doi.org/10.1111/j.1471-0528.2011.03070.x

[13]   Ray, J.G., Berger, H., Lipscombe, L.L., et al. (2010) Gestational Prediabetes: A New Term for Early Prevention? Indian Journal of Medical Research, 132, 251-255.

[14]   Foghsgaard, S., Andreasen, C., Vedtofte, L., et al. (2017) Nonalcoholic Fatty Liver Disease Is Prevalent in Women with Prior Gestational Diabetes Mellitus and Independently Associated with Insulin Resistance and Waist Circumference. Diabetes Care, 40, 109-116.
https://doi.org/10.2337/dc16-1017

[15]   Catalano, P.M. (2014) Trying to Understand Gestational Diabetes. Diabetic Medicine, 31, 273-281.
https://doi.org/10.1111/dme.12381

[16]   Ajmera, V.H., Gunderson, E.P., VanWagner, L.B., et al. (2016) Gestational Diabetes Mellitus Is Strongly Associated with Non-Alcoholic Fatty Liver Disease. American Journal of Gastroenterology, 111, 658-664.
https://doi.org/10.1038/ajg.2016.57

[17]   Khan, R., Bril, F., Cusi, K., et al. (2018) Modulation of Insulin Resistance in NAFLD. Hepatology.

[18]   Borrelli, A., Bonelli, P., Tuccillo, F.M., et al. (2018) Role of Gut Microbiota and Oxidative Stress in the Progression of Non-Alcoholic Fatty Liver Disease to Hepatocarcinoma: Current and Innovative Therapeutic Approaches. Redox Biology, 15, 467-479.
https://doi.org/10.1016/j.redox.2018.01.009

[19]   Singh, S., Osna, N.A. and Kharbanda, K.K. (2017) Treatment Options for Alcoholic and Non-Alcoholic Fatty Liver Disease: A Review. World Journal of Gastroenterology, 23, 6549-6570.
https://doi.org/10.3748/wjg.v23.i36.6549

[20]   Kim, D., Kim, W., Joo, S.K., et al. (2018) Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease. Liver International, 39, 332-341.
https://doi.org/10.1111/liv.13983

[21]   Raschi, E., Mazzotti, A., Poluzzi, E., et al. (2018) Pharmacotherapy of Type 2 Diabetes in Patients with Chronic Liver Disease: Focus on Nonalcoholic Fatty Liver Disease. Expert Opinion on Pharmacotherapy, 19, 1903-1914.
https://doi.org/10.1080/14656566.2018.1531126

[22]   Cable, E.E., Finn, P.D., Stebbins, J.W., et al. (2009) Reduction of Hepatic Steatosis in Rats and Mice after Treatment with a Liver-Targeted Thyroid Hormone Receptor Agonist. Hepatology, 49, 407-417.
https://doi.org/10.1002/hep.22572

[23]   Moreli, J.B., Morceli, G., De Luca, A.K., et al. (2012) Influence of Maternal Hyperglycemia on IL-10 and TNF-Alpha Production: The Relationship with Perinatal Outcomes. Journal of Clinical Immunology, 32, 604-610.
https://doi.org/10.1007/s10875-011-9634-3

[24]   Urbanek, M., Hayes, M.G., Lee, H., et al. (2012) The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes during Pregnancy. PLoS ONE, 7, e32958.
https://doi.org/10.1371/journal.pone.0032958

[25]   Charrez, B., Qiao, L. and Hebbard, L. (2016) Hepatocellular Carcinoma and Non-Alcoholic Steatohepatitis: The State of Play. World Journal of Gastroenterology, 22, 2494-2502.
https://doi.org/10.3748/wjg.v22.i8.2494

[26]   Zhou, T. and Qin, B. (2009) Advances in Research on Relationship between Adipocytokines and Nonalcoholic Fatty Liver and Insulin Resistance. World Chinese Journal of Digestion, 17, 3014-3018.
https://doi.org/10.11569/wcjd.v17.i29.3014

[27]   Pennington, K.A., Ramirez-Perez, F.I., Pollock, K.E., et al. (2016) Maternal Hyperleptinemia Is Associated with Male Offspring’s Altered Vascular Function and Structure in Mice. PLoS ONE, 11, e155377.

[28]   Yang, M., Peng, S., Li, W., et al. (2016) Relationships between Plasma Leptin Levels, Leptin G2548A, Leptin Receptor Gln223Arg Polymorphisms and Gestational Diabetes Mellitus in Chinese Population. Scientific Reports, 6, Article No. 23948.
https://doi.org/10.1038/srep23948

[29]   Hedderson, M.M., Darbinian, J., Havel, P.J., et al. (2013) Low Prepregnancy Adiponectin Concentrations Are Associated with a Marked Increase in Risk for Development of Gestational Diabetes Mellitus. Diabetes Care, 36, 3930-3937.
https://doi.org/10.2337/dc13-0389

[30]   Fuqua, J.S. and Rogol, A.D. (2013) Neuroendocrine Alterations in the Exercising Human: Implications for Energy Homeostasis. Metabolism, 62, 911-921.
https://doi.org/10.1016/j.metabol.2013.01.016

[31]   An, B.Q., Jiang, M., Cheng, Y.T., et al. (2016) Influence of Leptin Receptor Gene K109R Polymorphism on the Risk of Nonalcoholic Fatty Liver Disease and Its Interaction with PNPLA3 I148M Polymorphism. Chinese Journal of Hepatology, 24, 358-362.

[32]   An, B.Q., Lu, L.L., Yuan, C., et al. (2016) Leptin Receptor Gene Polymorphisms and the Risk of Non-Alcoholic Fatty Liver Disease and Coronary Atherosclerosis in the Chinese Han Population. Hepatitis Monthly, 16, e35055.
https://doi.org/10.5812/hepatmon.35055

[33]   Wang, H.H., Zhou, C.L., Lv, M., et al. (2018) Prenatal High Estradiol Exposure Induces Sex-Specific and Dietarily Reversible Insulin Resistance through Decreased Hypothalamic INSR. Endocrinology, 159, 465-476.
https://doi.org/10.1210/en.2017-03017

[34]   Zhang, Y. and Wu, H. (2016) Advances in Research on Postpartum Glucose Metabolism in Gestational Diabetes. Chinese Diabetes Journal, 8, 304-306.

[35]   Zhou, Y., Li, C., Qiao, B., et al. (2017) Changes of Estrogen and Estrogen Receptor Alpha Levels in Placental Tissues of Patients with Gestational Diabetes Mellitus and Related Factors. Chinese Diabetes Journal, 9, 688-692.

[36]   Geisler, C.E. and Renquist, B.J. (2017) Hepatic Lipid Accumulation: Cause and Consequence of Dysregulated Glucoregulatory Hormones. Journal of Endocrinology, 234, R1-R21.
https://doi.org/10.1530/JOE-16-0513

[37]   Chalasani, N., Younossi, Z., Lavine, J.E., et al. (2012) The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology, 142, 1592-1609.
https://doi.org/10.1053/j.gastro.2012.04.001

 
 
Top